Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Every investor in Axiata Group Berhad (KLSE:AXIATA) should be aware of the most powerful shareholder groups. With 52% stake, institutions possess the maximum shares in the company. In other words, the ...

Every generation believes they have figured out how to prevent the next financial crisis. The dot-com boom taught us that ...

Exact Sciences stock has seen its fair value price target rise slightly, moving from $69.16 to $70.25, as analyst sentiment shifts to reflect the company’s anticipated growth. This adjustment comes as ...

There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.

Is Entertainment really a risky business to invest in? 2 Companies from the sector are making others envious when it comes to Operating profits, Net profits, Profits on capital employed. All while ...

Foram feels the current pullback in Bank Nifty is a healthy technical consolidation, offering room for the index to take a breather before moving higher. The 57,300–57,500 zone ...

Photronics shows strong execution, buybacks, and solid demand drivers from AI, EUV, and OLED technologies supporting growth. See why PLAB stock is a buy.

Gentrification, infrastructure upgrades, rezoning, climate investments and shifting work patterns fueled up to 288% price growth in some NYC neighborhoods. Key Takeaways: 24 NYC neighborhoods saw ...